Jose Adelaide

CRCM, CNRS, Inserm, Institut Paoli-Calmettes
MARSEILLE France Papers:
1401 Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients